Sio Capital Management, LLC - Q2 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q2 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VIKING THERAPEUTICS INC24Q3 20233.4%
UNITED THERAPEUTICS ORD23Q3 20238.3%
CARDINAL HEALTH ORD20Q2 20227.2%
SANOFI SA19Q3 20229.8%
MEDTRONIC PLC18Q3 20235.2%
CATALYST BIOSCIENCES INC18Q3 202117.8%
PFENEX ORD18Q4 20195.9%
AEGLEA BIOTHERAPEUTICS INC18Q1 20231.1%
HCA HEALTHCARE INC17Q2 20225.5%
MCKESSON ORD17Q1 20226.0%

View Sio Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Sio Capital Management, LLC Q2 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Modular Medical, Inc.February 13, 20231,091,47910.0%
Cellectar Biosciences, Inc.February 10, 2022? ?
CURIS INCFebruary 10, 20223,866,6454.2%
Salarius Pharmaceuticals, Inc.February 10, 20221,354,2913.0%
Larimar Therapeutics, Inc.February 16, 2021188,6611.2%
ACHIEVE LIFE SCIENCES, INC.February 14, 2020? ?
Bionano Genomics, IncFebruary 14, 20201,210,8214.6%
Brickell Biotech, Inc.February 14, 2020? ?
Trillium Therapeutics Inc.February 14, 20202,751,1869.8%
ZAFGEN, INC.February 14, 20202,283,1646.1%

View Sio Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
SC 13G2023-02-13
13F-HR2022-11-14

View Sio Capital Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Sio Capital Management, LLC's holdings

CSVXLS